The 20th Annual Meeting of the International Conference on Genomics (ICG-20) successfully concluded at Sir Run Run Shaw Hospital

The 20th Annual Meeting of the International Conference on Genomics (ICG-20) thematic forum on "AI and Future Medicine" successfully concluded at Sir Run Run Shaw Hospital (SRRSH). This year's conference themed on "The Future of Omics and AI," where globally renowned experts met, including Academician Stephen J. O'Brien, former Director of the U.S. National Institutes of Health (NIH) and National Cancer Institute (NCI); Professor Ingemar Ernberg from the Karolinska Institute in Sweden; Professor Maria Masucci, a member of the Nobel Prize Review Committee; and Academician Yang Huanming, Chinese Academy of Sciences and Co-founder of BGI. Together, they explored the latest breakthroughs and future trends in life multi-omics.

Yang Huanming, Academician of the Chinese Academy of Sciences and Co-founder of BGI, noted that Hangzhou has profound connections with life science research. He mentioned that the first International Conference on Genomics was held in Hangzhou back in 2006, and BGI's research on both the rice genome and conservation genomics of giant pandas is closely linked to the city. He praised Hangzhou's significant role in the global life science sector and expressed his hope that it would yield more high-quality research outcomes in the future, making greater contributions to the advancement in the field.

Lin Jie, Member of the Party Committee and Deputy Director of the Zhejiang Provincial Health Commission, stated that the current technological revolution, represented by AI and biotechnology, is profoundly reshaping traditional medicine, bringing both significant development opportunities and challenges. As a pioneer in reform and opening-up and a leader in the digital economy, Zhejiang has identified AI in healthcare as a key development area. Leveraging advantages such as the national AI application pilot base, the province is building a comprehensive innovation ecosystem.

Xu Guobin, Secretary of the Party Committee of Sir Run Run Shaw Hospital, stated in his speech that the future of medicine lies in cross-disciplinary integration and intelligent innovation. As the flood of genomic data converges with the wave of AI, a profound medical revolution is underway—from accurately predicting protein structures to intelligently analyzing disease subtypes, AI is redefining the possibilities of healthcare. SRRSH has consistently adhered to the integration of medicine, engineering, and information technology, continuously expanding the boundaries and precision of medical services—from precision minimally invasive techniques to remote healthcare.

Yu Hong, Executive Deputy Secretary of the Party Committee of SRRSH, announced the opening of the "AI and Future Medicine" themed forum. Leading figures in omics, medicine, and AI from China and abroad delivered high-level keynote reports, engaging in in-depth discussions on how AI can empower omics research, advance precision medicine, and transform diagnostic models for complex diseases. The forum also featured profound deliberations on challenges arising from technological development, including data security, ethical standards, and the construction of regulatory frameworks.

The "AI and Future Medicine" forum specifically focused on the application and prospects of omics and AI technologies in the medical field, delving into a series of cutting-edge topics such as oncology, P4 medicine, organ-on-a-chip technology, and embodied intelligent robotics. From accurately predicting protein structures to intelligently analyzing diseases, a profound medical revolution is unfolding. This event not only paid tribute to the Human Genome Project launched 25 years ago but also served as a declaration of a new era of AI-empowered healthcare.